• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Articles
    • Children’s Health
    • Diseases & Conditions
    • Healthy Living
    • Men’s Health
    • Sexual Health
    • Women’s Health
  • Books
    • Children’s Health
    • Diseases & Conditions
    • Healthy Living
    • Men’s Health
    • Sexual Health
    • Women’s Health
  • Videos
    • Children’s Health
    • Diseases & Conditions
    • Healthy Living
    • Men’s Health
    • Sexual Health
    • Women’s Health
  • About
  • Contact

Preventive Medicine Daily

Your source for the latest news on preventive medicine and public health

  • News
  • Diseases & Conditions
    • Blood
    • Cancer
    • Circulatory System
    • Congenital
    • Digestive System
    • Ear
    • Endocrine
    • Eye
    • Genitourinary
    • Infectious Diseases
    • Injuries
    • Mental Disorders
    • Metabolic Diseases
    • Musculoskeletal
    • Nervous System
    • Respiratory System
    • Skin
  • Healthy Living
    • Addictions
    • Children’s Health
    • Men’s Health
    • Women’s Health
      • Pregnancy
      • Childbirth
    • Sexual Health
    • Exercise
    • Nutrition
You are here: Home / Diseases & Conditions / Blood / NIH Scientists Find The Cause Of Cold Urticaria

NIH Scientists Find The Cause Of Cold Urticaria

January 14, 2012 By pmdaily Leave a Comment

Genetic mutation leads to cold allergy, immune deficiency and autoimmunity

Investigators at the National Institutes of Health have identified a genetic mutation in three unrelated families that causes a rare immune disorder characterized by excessive and impaired immune function. Symptoms of this condition include immune deficiency, autoimmunity, inflammatory skin disorders and cold-induced hives, a condition known as cold urticaria.

The study was led by Joshua Milner, M.D., in the Laboratory of Allergic Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), and Daniel Kastner, M.D., Ph.D., scientific director at the National Human Genome Research Institute (NHGRI). It will appear in the online edition of the New England Journal of Medicine on Jan. 11, 2012.

The mutation discovered occurs in a gene for phospholipase C-gamma2 (PLCG2), an enzyme involved in the activation of immune cells. The investigators have named the condition PLCG2-associated antibody deficiency and immune dysregulation, or PLAID. “Investigating rare diseases gives researchers more clues about how the healthy immune system functions,” says NIAID Director Anthony S. Fauci, M.D. “More importantly, identifying the genetic cause of these disorders opens up possibilities for better disease management and potentially a cure for people who may have spent their entire lives debilitated by severe and unexplained symptoms.”

The NIH study involved 27 people from three separate families who all suffered from an inherited form of cold urticaria, an allergic disease characterized by the formation of itchy, sometimes painful hives, episodes of fainting and, in certain cases, life-threatening reactions in response to cold temperatures.

Blood sample analysis revealed that many patients produced antibodies to their own cells and tissues (autoantibodies), making them more susceptible to developing autoimmune disease. More than half had a history of recurrent infections, and laboratory tests revealed that most had low levels of infection-fighting antibodies and low numbers and reduced activity of circulating immune B cells — all symptoms of immune deficiency disease. In three cases, patients had common variable immunodeficiency, a disease that requires frequent intravenous infusions of immune globulin to prevent severe infections. Seven patients suffered from granulomas, inflamed masses of tissue, which formed on their fingers, ears, nose and other parts of their skin.

“This is one of few examples in which the allergy symptom directed us to a genetic syndrome,” says Dr. Milner. “In trying to understand the link between this group of conditions — autoimmunity, chronic infections and cold urticaria—we not only identified a disease-causing mutation but uncovered a unique and fascinating genetic mechanism at the crux of allergy, immune defense and self-tolerance.”

“This study illustrates the power of multidisciplinary teamwork involving clinicians, geneticists and basic immunologists to get to the heart of seemingly insoluble medical mysteries,” says Dr. Kastner. “Our team and colleagues working in the field now have much better odds of improving health outcomes for people with PLAID and for understanding this gene’s role in other disorders.”

The NIAID investigators teamed up with gene hunting experts in Dr. Kastner’s laboratory and found the PLCG2 mutation after performing gene analysis and DNA sequencing studies. The mutation caused the PLCG2 enzyme to function without shutting off. Despite the fact that the enzyme was constantly turned on, immune cells ignored its signaling and did not activate normally.

Investigators performed a series of laboratory experiments to understand how the PLCG2 mutation affects B cells and mast cells, immune cells that contain histamine and other chemicals that are released during an allergic response. Patients’ B cells containing the mutated gene fail to turn on normally, leading to their inability to produce antibody, but also an inability to sense when they are producing autoantibodies. Laboratory-developed mast cells containing the mutated gene released chemicals on exposure to cool temperatures, which could explain why the patients developed cold-induced hives.

According to the investigators, their findings suggest that inhibiting PLCG2 activity could be a therapeutic strategy to treat cold-induced hives, autoimmunity and immune deficiency in people with PLAID, but more studies are needed. The study findings also suggest that people previously diagnosed with common variable immunodeficiency disease or with granulomatous diseases could have a PLCG2 gene mutation. Further study is needed to understand PLAID and how mutations in PLCG2 could contribute to other allergic and immunologic disorders.

“These findings are gratifying both for researchers and for people with this disorder,” says NHGRI Director Eric Green, M.D., Ph.D. “Furthermore, this study illustrates how genome-analysis methods can empower efforts to unravel the molecular basis of rare genetic diseases.”

Additional support for this work was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the NIH.

The mission of the NIAMS, a part of the U.S. Department of Health and Human Services’ National Institutes of Health, is to support research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. For more information about the NIAMS, call the information clearinghouse at (301) 495-4484 or (877) 22-NIAMS (free call) or visit the NIAMS website at http://www.niams.nih.gov.

NIAID conducts and supports research  — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

NHGRI is one of the 27 institutes and centers at the NIH, an agency of the Department of Health and Human Services. The NHGRI Division of Intramural Research develops and implements technology to understand, diagnose and treat genomic and genetic diseases. Additional information about NHGRI can be found at its website, www.genome.gov.

Story Source:

The above story is reprinted from materials provided by NIH.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Disclaimer: Views expressed in this article do not necessarily reflect those of PreventiveMedicineDaily or its staff.

Filed Under: Blood Tagged With: autoimmune diseases, cold urticaria

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

RSS
Follow by Email
Facebook
Facebook
fb-share-icon
Twitter
Tweet

Recent posts

How Many Carbs Per Day On A Keto Diet?

How many carbs should I eat per day if I am on a keto diet? This is a very frequent question we … [Read More...] about How Many Carbs Per Day On A Keto Diet?

Pairing Protein and Carbs for Better Nutrition

Healthy carb choices plus healthy protein choices work together for a better and more balanced … [Read More...] about Pairing Protein and Carbs for Better Nutrition

Measles cases at ‘alarmingly’ high levels around the world, UNICEF says

Measles cases at ‘alarmingly’ high levels around the world, UNICEF says CNN News February 28, 2019 … [Read More...] about Measles cases at ‘alarmingly’ high levels around the world, UNICEF says

  • A Trial for Prevention of Loss of the Effect of Biological Drugs in Patients With Inflammatory Bowel Disease
  • Mediterranean diets reduce risk of heart disease – new research shows
  • Why being deficient in vitamin C puts you at extreme risk of various diseases
  • Canadian children still not getting enough vitamin D… cancer rates continue to climb

RSS Latest Public Health Headlines

  • WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globally
  • WHO concerned about suspected chemical attacks in Syria
  • Nearly one billion people in Africa to be protected against yellow fever by 2026
  • WHO at 70 - working for better health for everyone, everywhere
  • Donors pledge over US$ 15 million to WHO’s Contingency Fund for Emergencies

Footer

Main Menu

  • Home
  • About
  • Contact

Copyright 2020 PreventiveMedicineDaily.com | Privacy | Terms | DMCA | Disclaimer